{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:08:04Z","timestamp":1776146884822,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,2,27]],"date-time":"2004-02-27T00:00:00Z","timestamp":1077840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prenatal Diagnosis"],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Invasive trophoblast antigen (ITA), also known as hyperglycosylated hCG, is a glycosylation variant of hCG produced by invasive cytotrophoblast cells. Publications show that ITA is potentially a sensitive test for Down syndrome screening, reportedly detecting 38 and 80% of cases at a 5% false\u2010positive rate in the first and second trimesters of pregnancy respectively. ITA has six oligosaccharides varying greatly in terminal sialic acid content (0\u201319 residues), leading to wide\u2010charge heterogeneity. With the objective of developing an improved Down syndrome screening test, we examined the charge, or sialic acid variants, of ITA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty urine samples were collected from the 16th to 18th week of gestation from 10 patients with trisomy 21 fetuses, demonstrated by karyotype analysis, and from 10 patients with normal karyotype pregnancies. Proteins in each sample were separated by preparative isoelectric focusing. Fractions were collected, pooled into the pl ranges of 3.0 to 4.0, 4.1 to 5.0, 5.1 to 6.0 and 6.1 to 7.0 and assayed for ITA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A difference in the distribution of ITA charge variants was demonstrated between cases and controls, most apparent in the less acidic (pl 5.1\u20137.0) range. The controls and Down syndrome samples contained 26.7 \u00b1 14% versus 45.6 \u00b1 20%, respectively, of the less acidic form of ITA (<jats:italic>P<\/jats:italic> = 0.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The ITA in Down syndrome cases is composed of a much higher proportion of less acidic ITA. This could be the major source of elevated levels of ITA in Down syndrome pregnancies. It is postulated that the development of a new assay specifically measuring ITA that is deficient in sialic acid might enhance the utility of the already highly sensitive screening tests for Down syndrome. Copyright \u00a9 2004 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pd.836","type":"journal-article","created":{"date-parts":[[2004,3,29]],"date-time":"2004-03-29T08:03:07Z","timestamp":1080547387000},"page":"194-197","source":"Crossref","is-referenced-by-count":18,"title":["Sialic acid\u2013deficient invasive trophoblast antigen (sd\u2010ITA): a new urinary variant for gestational Down syndrome screening"],"prefix":"10.1002","volume":"24","author":[{"given":"Jaime M.","family":"Sutton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence A.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,2,27]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"75","article-title":"Discrepancy between the effects of desialylation of human chorionic gonadotropin on in vitro ovarian biological activity and on receptor binding","volume":"95","author":"Brand EC","year":"1980","journal-title":"Acta Endocrinol"},{"key":"e_1_2_1_3_1","first-page":"30","article-title":"Screening for Down syndrome using maternal serum alpha\u2010fetoprotein, unconjugated estriol and hCG","volume":"13","author":"Canick JA","year":"1990","journal-title":"J Clin Immunol"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(03)00108-5"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199809)18:9<926::AID-PD377>3.0.CO;2-F"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.2.308"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/45.12.2109"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199910)19:10<918::AID-PD680>3.0.CO;2-4"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02778058"},{"key":"e_1_2_1_10_1","first-page":"1033","article-title":"Failure of differentiation of the trophoblast in trisomy 21","volume":"184","author":"Evain\u2010Brion D","year":"2000","journal-title":"Bull Acad Natl Med"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.10.3700"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/jms.5.3.115"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(87)90252-X"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(02)00135-1"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/plac.2001.0658"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349456"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-59-6-1215"},{"key":"e_1_2_1_19_1","unstructured":"StromCM PalomakiGE KnightGJ ColeLA LeeJES PandianR.2001.Maternal urine invasive trophoblastic antigen (ITA) is a useful marker for Down syndrome detection in the 1st trimester. 51st Annual Meeting of the American Society of Human Genetics San Diego CA (Abstract 2839)."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-89-1-11"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0223(200012)20:12<976::AID-PD962>3.0.CO;2-2"}],"container-title":["Prenatal Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpd.836","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pd.836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T23:07:10Z","timestamp":1692486430000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/pd.836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,27]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1002\/pd.836"],"URL":"https:\/\/doi.org\/10.1002\/pd.836","archive":["Portico"],"relation":{},"ISSN":["0197-3851","1097-0223"],"issn-type":[{"value":"0197-3851","type":"print"},{"value":"1097-0223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,27]]}}}